{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:44:00Z","timestamp":1793835840443,"version":"4.6.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteoporosis is a metabolic bone disease characterized by decreased bone mass and increased fracture risk. Bone turnover markers, such as osteocalcin (OC), undercarboxylated osteocalcin (ucOC), and other biochemical indicators, are important for assessing bone metabolism. Vitamin K2 influences bone metabolism by enhancing osteocalcin \u03b3-carboxylation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study followed PRISMA guidelines and included randomized controlled trials on the effects of vitamin K2 supplementation on bone turnover biomarkers in postmenopausal osteoporosis patients. Key outcomes included changes in OC, ucOC, and other bone metabolism markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine studies with 2,570 participants were included. Vitamin K2 (VK2) increased osteocalcin (OC; MD 1.86, 95% CI 1.17\u20132.56) and bone-specific alkaline phosphatase (BAP; MD 1.49, 95% CI 0.98\u20132.00). It reduced undercarboxylated OC (ucOC; WMD \u22121.54, 95% CI \u22122.44 to \u22120.64) and tartrate-resistant acid phosphatase (TRAP; MD \u22120.83, 95% CI \u22121.21 to \u22120.46). C-terminal telopeptide (CTX) showed a small, statistically significant reduction (MD \u22120.09, 95% CI \u22120.14 to \u22120.05) with uncertain clinical relevance. N-telopeptide (NTX) showed no significant change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vitamin K2 supplementation improves key bone turnover biomarkers, particularly OC and ucOC. These findings support its role in bone metabolism, though further long-term studies are needed to confirm clinical benefits, such as increased bone mineral density.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251087067<\/jats:uri>\n                      , identifier CRD420251087067.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1703116","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:21:24Z","timestamp":1762320084000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The effect of vitamin K2 supplementation on bone turnover biochemical markers in postmenopausal osteoporosis patients: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Zechen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s13018-021-02772-0","article-title":"The global prevalence of osteoporosis in the world: A comprehensive systematic review and meta-analysis","volume":"16","author":"Salari","year":"2021","journal-title":"J Orthop Surg Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.870905","article-title":"Global, regional, and national burden of low bone mineral density from 1990 to 2019: results from the global burden of disease study 2019","volume":"13","author":"Dong","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2022.09.002","article-title":"Current use of bone turnover markers in the management of osteoporosis","author":"Brown","year":"2022","journal-title":"Clin Biochem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"14844","DOI":"10.1038\/s41598-024-65952-y","article-title":"Changes in Bone Turnover Markers 6\u201312 months after Bariatric Surgery","volume":"14","author":"Farup","year":"2024","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.843912","article-title":"Undercarboxylated osteocalcin and its associations with bone mineral density, bone turnover markers, and prevalence of osteopenia and osteoporosis in Chinese population: A cross-sectional study","volume":"13","author":"Xu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1801323","DOI":"10.1002\/mnfr.201801323","article-title":"The presence of pulses within a meal can alter fat-soluble vitamin bioavailability","volume":"63","author":"Margier","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"B7","article-title":"Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis","volume":"17","author":"Flore","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/nu16142356","article-title":"Investigating the effects and mechanisms of combined vitamin D and K supplementation in postmenopausal women: an up-to-date comprehensive review of clinical studies","volume":"16","author":"Rusu","year":"2024","journal-title":"Nutrients"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194082","article-title":"Vitamin K-dependent carboxylation of osteocalcin in bone-ally or adversary of bone mineral status in rats with experimental chronic kidney disease","volume":"14","author":"Ziemi\u0144ska","year":"2022","journal-title":"Nutrients"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-024-02418-8","article-title":"Current knowledge of bone-derived factor osteocalcin: its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis and inflammatory joint diseases","volume":"102","author":"Martiniakova","year":"2024","journal-title":"J Mol Med (Berl)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14618","article-title":"Structural and mutational analyses of decarboxylated osteocalcin provide insight into its adiponectin-inducing activity","volume":"597","author":"Mizuguchi","year":"2023","journal-title":"FEBS Lett"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cells13080681","article-title":"Pregnane X receptor signaling pathway and vitamin K: molecular mechanisms and clinical relevance in human health","volume":"13","author":"Staudinger","year":"2024","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/nu16152420","article-title":"The importance of vitamin K and the combination of vitamins K and D for calcium metabolism and bone health: A review","volume":"16","author":"Aaseth","year":"2024","journal-title":"Nutrients"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.896920","article-title":"Molecular pathways and roles for vitamin K2\u20137 as a health-beneficial nutraceutical: challenges and opportunities","volume":"13","author":"Jadhav","year":"2022","journal-title":"Front Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.979649","article-title":"Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Ma","year":"2022","journal-title":"Front Public Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1302\/2046-3758.1312.Bjr-2024-0053.R1","article-title":"Effects of vitamin K supplementation on bone mineral density at different sites and bone metabolism in the middle-aged and elderly population","volume":"13","author":"Xie","year":"2024","journal-title":"Bone Joint Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-013-2325-6","article-title":"Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women","volume":"24","author":"Knapen","year":"2013","journal-title":"Osteoporos Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05638-z","article-title":"The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial","volume":"32","author":"R\u00f8nn","year":"2021","journal-title":"Osteoporos Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.12.1256","article-title":"Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials","volume":"166","author":"Cockayne","year":"2006","journal-title":"Arch Intern Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.3.515","article-title":"Vitamin K2 (Menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis","volume":"15","author":"Shiraki","year":"2000","journal-title":"J Bone Miner Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s13018-021-02728-4","article-title":"The combined effect of vitamin K and calcium on bone mineral density in humans: A meta-analysis of randomized controlled trials","volume":"16","author":"Hu","year":"2021","journal-title":"J Orthop Surg Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","article-title":"Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: A consensus paper from the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO), international osteoporosis foundation (IOF), and international federation of clinical chemistry and laboratory medicine (IFCC)","volume":"36","author":"Bhattoa","year":"2025","journal-title":"Osteoporos Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.metabol.2017.02.006","article-title":"Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D(3) administration","volume":"70","author":"Alvarez","year":"2017","journal-title":"Metabolism"},{"key":"B24","first-page":"49","article-title":"Effects and safety of menatetrenone combined with zoledronic acid on refracture after percutaneous vertebroplasty (PVP) in postmenopausal patients with osteoporotic fractures","volume":"9","author":"Zheng","year":"2022","journal-title":"Electronic J Clin Med Literature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1673-016X.2022.02.015","article-title":"Efficacy of percutaneous kyphoplasty (PKP) combined with menatetrenone in postmenopausal women with osteoporotic thoracolumbar compression fractures","volume":"19","author":"Wei","year":"2022","journal-title":"J Hunan Normal Univ (Medical Sciences)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-7108.2021.02.023","article-title":"Clinical efficacy of vitamin K2 combined with imidapril in elderly women with osteoporosis and hypertension","volume":"27","author":"Xu","year":"2021","journal-title":"Chin J Osteoporosis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.13621\/j.1001-5949.2020.10.0929","article-title":"Clinical efficacy of menatetrenone combined with zoledronic acid in postmenopausal women with type 2 diabetes and osteoporosis","volume":"42","author":"Fu","year":"2020","journal-title":"Ningxia Med J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-013-0490-5","article-title":"Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis","volume":"32","author":"Kasukawa","year":"2014","journal-title":"J Bone Miner Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-008-0034-6","article-title":"Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: A randomized prospective study","volume":"27","author":"Shiraki","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2006.00386.x","article-title":"Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia","volume":"32","author":"Purwosunu","year":"2006","journal-title":"J Obstet Gynaecol Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v18i1.27","article-title":"Effect of vitamin K2 on bone mineral density and serum cathepsin K in female osteoporosis patients","volume":"18","author":"Gu","year":"2019","journal-title":"Trop J Pharm Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-016-0768-5","article-title":"Comparison of concurrent treatment with vitamin K(2) and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese osteoporosis intervention trial-03","volume":"35","author":"Tanaka","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.081254","article-title":"Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women","volume":"24","author":"Binkley","year":"2009","journal-title":"J Bone Miner Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.25.050304.092713","article-title":"The vitamin K-dependent carboxylase","volume":"25","author":"Berkner","year":"2005","journal-title":"Annu Rev Nutr"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20123006","article-title":"New aspects of vitamin K research with synthetic ligands: transcriptional activity via SXR and neural differentiation activity","volume":"20","author":"Hirota","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101158","article-title":"Melatonin-micronutrients osteopenia treatment study (MOTS): A translational study assessing melatonin, strontium (Citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind rct and on osteoblast-osteoclast co-cultures","volume":"9","author":"Maria","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M303136200","article-title":"Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR","volume":"278","author":"Tabb","year":"2003","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0119177","DOI":"10.1371\/journal.pone.0119177","article-title":"Pregnane X receptor knockout mice display aging-dependent wearing of articular cartilage","volume":"10","author":"Azuma","year":"2015","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.3.431","article-title":"Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro","volume":"12","author":"Koshihara","year":"1997","journal-title":"J Bone Miner Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4082-4","article-title":"Use of CTX-I and PINP as bone turnover markers: national bone health alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability","volume":"28","author":"Szulc","year":"2017","journal-title":"Osteoporos Int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s8756-3282(02)00791-3","article-title":"Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (Serum CTX): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting","volume":"31","author":"Qvist","year":"2002","journal-title":"Bone"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-022-00965-1","article-title":"A systematic review of the circadian rhythm of bone markers in blood","volume":"112","author":"Diemar","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2490","article-title":"Effect of vitamin K supplementation on bone loss in elderly men and women","volume":"93","author":"Booth","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-012-9571-z","article-title":"Changes in parameters of bone metabolism in postmenopausal women following a 12-month intervention period using dairy products enriched with calcium, vitamin D, and phylloquinone (Vitamin K(1)) or menaquinone-7 (Vitamin K (2)): the postmenopausal health study II","volume":"90","author":"Kanellakis","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"B45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos Int"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1703116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:21:27Z","timestamp":1762320087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1703116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":45,"alternative-id":["10.3389\/fendo.2025.1703116"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1703116","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"article-number":"1703116"}}